...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Idea for Zenith
3
Jul 13, 2021 07:39PM
2
Jul 14, 2021 08:25AM
8
Jul 14, 2021 10:03AM
1
Jul 14, 2021 10:48AM
2
Jul 14, 2021 11:07AM
3
Jul 14, 2021 11:17AM
4
Jul 14, 2021 11:48AM
4
Jul 16, 2021 12:55PM

"the RVX preferreds may have a great deal of value at some point."

the "ZHCLF" shares trading on the OTC, do they carry with them the Resverlogix Royalty Preferred Shares that are entitled to dividends in the amount of 6-12 % of Resverlogix's net revenue if any. 

 

Koo

2
Jul 16, 2021 06:08PM
3
Jul 25, 2021 08:35PM
Share
New Message
Please login to post a reply